Who owns Eupraxia Pharmaceuticals Inc.?
Institutional ownership of EPRX from SEC Form 13F filings across 40 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
40
13F holders
$73.8M
value, 2026 filers
44.5%
of shares outstanding (14.9M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of EPRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Beutel, Goodman & Co Ltd. | 3.6M | $23,806 | 0.2% | 10.8% | -1.1% |
| 2 | Balyasny Asset Management L.P. | 1.4M | $8.9M | 0.0% | 4% | 0.0% |
| 3 | SCOTIA CAPITAL INC. | 1.3M | $8.8M | 0.0% | 4% | +0.1% |
| 4 | GREAT POINT PARTNERS LLC | 1.2M | $7.9M | 1.5% | 3.6% | 0.0% |
| 5 | Jupiter Topco LLCNEW | 1.0M | $6.9M | 0.0% | 3.1% | new |
| 6 | Woodline Partners LP | 746,864 | $4.9M | 0.0% | 2.2% | -15.2% |
| 7 | Point72 Asset Management, L.P. | 730,284 | $4.8M | 0.0% | 2.2% | -24.5% |
| 8 | AMERIPRISE FINANCIAL INC | 711,024 | $4.7M | 0.0% | 2.1% | +35.6% |
| 9 | UBS Group AG | 519,211 | $3.4M | 0.0% | 1.6% | -31.9% |
| 10 | CITADEL ADVISORS LLC | 502,011 | $3.3M | 0.0% | 1.5% | +118.1% |
| 11 | MILLENNIUM MANAGEMENT LLCNEW | 441,586 | $2.9M | 0.0% | 1.3% | new |
| 12 | PICTON MAHONEY ASSET MANAGEMENTNEW | 360,878 | $2.4M | 0.0% | 1.1% | new |
| 13 | JANE STREET GROUP, LLC | 329,053 | $2.2M | 0.0% | 1% | +834.5% |
| 14 | ROYAL BANK OF CANADA | 311,435 | $2.1M | 0.0% | 0.9% | +19.2% |
| 15 | BANK OF AMERICA CORP /DE/ | 264,721 | $1.7M | 0.0% | 0.8% | -1.3% |
| 16 | CIBC WORLD MARKET INC. | 234,673 | $1.5M | 0.0% | 0.7% | +55.5% |
| 17 | TWO SIGMA INVESTMENTS, LP | 221,084 | $1.5M | 0.0% | 0.7% | +1947.1% |
| 18 | BOOTHBAY FUND MANAGEMENT, LLC | 212,653 | $1.4M | 0.0% | 0.6% | -34.3% |
| 19 | MARSHALL WACE, LLP | 158,133 | $1.0M | 0.0% | 0.5% | 0.0% |
| 20 | TD Waterhouse Canada Inc. | 79,607 | $534,915 | 0.0% | 0.2% | -2.6% |
| 21 | INGALLS & SNYDER LLC | 68,450 | $452 | 0.0% | 0.2% | -9.5% |
| 22 | GOLDMAN SACHS GROUP INC | 58,058 | $383,763 | 0.0% | 0.2% | +9.4% |
| 23 | RAYMOND JAMES FINANCIAL INC | 53,503 | $353,655 | 0.0% | 0.2% | +5.8% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 46,145 | $305,018 | 0.0% | 0.1% | +617.8% |
| 25 | BANK OF MONTREAL /CAN/ | 38,457 | $252,195 | 0.0% | 0.1% | +0.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.